Review Article| Volume 6, ISSUE 1, P71-87, May 2023

Download started.


Energy-Based Devices for Vulvovaginal Rejuvenation

  • George Kroumpouzos
    Corresponding author. GK Dermatology, PC, 541 Main Street, Suite 320, South Weymouth, MA 02190, USA.
    Department of Dermatology, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island, USA

    GK Dermatology, PC, 541 Main Street, Suite 320, South Weymouth, MA 02190, USA
    Search for articles by this author
  • Sejal Ajmera Desai
    Indian Academy of Vaginal Aesthetics (IAVA), 7 Sukhmani, Juhu Himalaya CHS LTD, Guru Nanak Marg, N S Road NO. 10, JVPD Scheme, Vile Parle (West), Mumbai 400049, India
    Search for articles by this author
  • Tassahil Messas
    Department of Dermatology, University Hospital Centre, University of Constantine III, Service de Dermatologie, Centre Hospitalo Universitaire Ben Badis, Rue Benseghir Abdelouahab, Constantine 25000, Algeria
    Search for articles by this author


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Cosmetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Barbara G.
        • Facchin F.
        • Buggio L.
        • et al.
        Vaginal rejuvenation: current perspectives.
        Int J Womens Health. 2017; 9: 513-519
        • Desai S.A.
        • Kroumpouzos G.
        • Sadick N.
        Vaginal rejuvenation: from scalpel to wands.
        Int J Womens Dermatol. 2019; 5: 79-84
        • Gambacciani M.
        • Levancini M.
        • Cervigni M.
        Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
        Climacteric. 2015; 18: 757-763
        • Gambacciani M.
        • Torelli M.G.
        • Martella L.
        • et al.
        Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
        Climacteric. 2015; 18: 43-48
        • Gaspar A.
        • Silva J.
        • Calderon A.
        • et al.
        Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy.
        Climacteric. 2020; 23: S11-S13
        • Athanasiou S.
        • Pitsouni E.
        • Antonopoulou S.
        • et al.
        The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women.
        Climacteric. 2016; 19: 512-518
        • Pagano T.
        • Travaglino A.
        • Raffone A.
        • et al.
        Fractional microablative CO2 laser-related histological changes on vulvar tissue in patients with genitourinary syndrome of menopause.
        Lasers Surg Med. 2021; 53: 521-527
        • Ahluwalia J.
        • Avram M.M.
        • Ortiz A.E.
        Lasers and energy-based devices marketed for vaginal rejuvenation: A cross-sectional analysis of the MAUDE database.
        Lasers Surg Med. 2019; 51: 671-677
        • Gambacciani M.
        • Cervigni M.
        • Gaspar A.
        • et al.
        Safety of vaginal erbium laser: a review of 113,000 patients treated in the past 8 years.
        Climacteric. 2020; 23: S28-S32
        • Messas T.
        • Messas A.
        • Kroumpouzos G.
        Carbon dioxide laser vulvovaginal rejuvenation: a systematic review.
        Cosmetics. 2021; 8: 56
        • Tanzi E.L.
        • Lupton J.R.
        • Alster T.S.
        Lasers in dermatology: four decades of progress.
        J Am Acad Dermatol. 2003; 49: 1-34
        • Snoeckx L.H.
        • Cornelussen R.N.
        • Van Nieuwenhoven F.A.
        • et al.
        Heat shock proteins and cardiovascular pathophysiology.
        Physiol Rev. 2001; 81: 1461-1497
        • Zerbinati N.
        • Serati M.
        • Origoni M.
        • et al.
        Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment.
        Lasers Med Sci. 2015; 30: 429-436
        • Perino A.
        • Calligaro A.
        • Forlani F.
        • et al.
        Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
        Maturitas. 2015; 80: 296-301
        • Miao Y.
        • Sudol N.T.
        • Li Y.
        • et al.
        OCT Evaluation of vaginal epithelial thickness during CO2 laser treatment: a pilot study.
        J Biophotonics. 2022; 15 ([published online ahead of print, 2022 Jul 20]): e202200052
        • Pieralli A.
        • Bianchi C.
        • Longinotti M.
        • et al.
        Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy (VVA) symptoms.
        Arch Gynecol Obstet. 2017; 296 (erratum published in Arch Gynecol Obstet. 2017 Sep 27): 973-978
        • Salvatore S.
        • França K.
        • Lotti T.
        • et al.
        Early regenerative modifications of human postmenopausal atrophic vaginal mucosa following fractional CO2 laser treatment.
        Open Access Maced J Med Sci. 2018; 6: 6-14
        • Bretas T.L.B.
        • Issa M.C.A.
        • Fialho S.C.A.V.
        • et al.
        Vaginal collagen I and III changes after carbon dioxide laser application in postmenopausal women with the genitourinary syndrome: a pilot study.
        Climacteric. 2022; 25: 186-194
        • Veron L.
        • Wehrer D.
        • Annerose-Zéphir G.
        • et al.
        Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up.
        Breast Cancer Res Treat. 2021; 188: 501-509
        • Dutra P.F.S.P.
        • Heinke T.
        • Pinho S.C.
        • et al.
        Comparison of topical fractional CO2 laser and vaginal estrogen for the treatment of genitourinary syndrome in postmenopausal women: a randomized controlled trial.
        Menopause. 2021; 28: 756-763
        • Li F.G.
        • Maheux-Lacroix S.
        • Deans R.
        • et al.
        Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial.
        JAMA. 2021; 326: 1381-1389
        • Cruz V.L.
        • Steiner M.L.
        • Pompei L.M.
        • et al.
        Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
        Menopause. 2018; 25: 21-28
        • Politano C.A.
        • Costa-Paiva L.
        • Aguiar L.B.
        • et al.
        Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial.
        Menopause. 2019; 26: 833-840
        • Paraiso M.F.R.
        • Ferrando C.A.
        • Sokol E.R.
        • et al.
        A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial.
        Menopause. 2020; 27: 50-56
        • Eftekhar T.
        • Forooghifar T.
        • Khalili T.
        • et al.
        The effect of the CO2 fractional laser or Premarin vaginal cream on improving sexual function in menopausal women: a randomized controlled trial.
        J Lasers Med Sci. 2020; 11: 292-298
        • Li J.
        • Li H.
        • Zhou Y.
        • et al.
        The fractional CO2 laser for the treatment of genitourinary syndrome of menopause: a prospective multicenter cohort study.
        Lasers Surg Med. 2021; 53: 647-653
        • Ruanphoo P.
        • Bunyavejchevin S.
        Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial.
        Menopause. 2020; 27: 858-863
        • Salvatore S.
        • Pitsouni E.
        • Grigoriadis T.
        • et al.
        CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial.
        Climacteric. 2021; 24: 187-193
        • Cruff J.
        • Khandwala S.
        A double-blind randomized sham-controlled trial to evaluate the efficacy of fractional carbon dioxide laser therapy on genitourinary syndrome of menopause.
        J Sex Med. 2021; 18: 761-769
        • Lou W.
        • Chen F.
        • Xu T.
        • et al.
        A randomized controlled study of vaginal fractional CO2 laser therapy for female sexual dysfunction.
        Lasers Med Sci. 2022; 37: 359-367
        • Alvisi S.
        • Lami A.
        • Baldassarre M.
        • et al.
        Short-term efficacy and safety of non-ablative laser treatment alone or with estriol or moisturizers in postmenopausal women with vulvovaginal atrophy.
        J Sex Med. 2022; 19: 761-770
        • Lauterbach R.
        • Aharoni S.
        • Farago N.
        • et al.
        Maintenance laser treatment for vaginal looseness and sexual dysfunction: a double-blinded randomized controlled trial.
        J Sex Med. 2022; 19: 1404-1411
        • Behnia-Willison F.
        • Sarraf S.
        • Miller J.
        • et al.
        Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause.
        Eur J Obstet Gynecol Reprod Biol. 2017; 213: 39-44
        • Rosner-Tenerowicz A.
        • Zimmer-Stelmach A.
        • Zimmer M.
        The CO2 ablative laser treatment in perimenopausal patients with vulvovaginal atrophy.
        Ginekol Pol. 2021;
        • Filippini M.
        • Del Duca E.
        • Negosanti F.
        • et al.
        Fractional CO2 laser: from skin rejuvenation to vulvo-vaginal reshaping.
        Photomed Laser Surg. 2017; 35: 171-175
        • Marin J.
        • Lipa G.
        • Dunet E.
        The results of new low dose fractional CO2 Laser - a prospective clinical study in France.
        J Gynecol Obstet Hum Reprod. 2020; 49: 101614
        • Quick A.M.
        • Zvinovski F.
        • Hudson C.
        • et al.
        Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy.
        Menopause. 2021; 28: 642-649
        • Quick A.M.
        • Hundley A.
        • Evans C.
        • et al.
        Long-term follow-up of fractional CO2 laser therapy for genitourinary syndrome of menopause in breast cancer survivors.
        J Clin Med. 2022; 11: 774
        • Dizon D.S.
        Quality of life after breast cancer: survivorship and sexuality.
        Breast J. 2009; 15: 500-504
        • Pieralli A.
        • Fallani M.G.
        • Becorpi A.
        • et al.
        Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
        Arch Gynecol Obstet. 2016; 294: 841-846
        • Salvatore S.
        • Nappi R.E.
        • Casiraghi A.
        • et al.
        Microablative fractional CO2 laser for vulvovaginal atrophy in women with a history of breast cancer: a pilot study at 4-week follow-up.
        Clin Breast Cancer. 2021; 21: e539-e546
        • Mension E.
        • Alonso I.
        • Castelo-Branco C.
        Genitourinary syndrome of menopause: current treatment options in breast cancer survivors - systematic review.
        Maturitas. 2021; 143: 47-48
        • Mitchell C.M.
        How do we measure success in the treatment of genitourinary syndrome of menopause?.
        Menopause. 2020; 27: 844-845
        • Athanasiou S.
        • Pitsouni E.
        • Falagas M.E.
        • et al.
        CO2-laser for the genitourinary syndrome of menopause. How many laser sessions?.
        Maturitas. 2017; 104: 24-28
        • Samuels J.B.
        • Garcia M.A.
        Treatment to external labia and vaginal canal with CO2 laser for symptoms of vulvovaginal atrophy in postmenopausal women.
        Aesthet Surg J. 2019; 39: 83-93
        • Guo J.Z.
        • Souders C.
        • McClelland L.
        • et al.
        Vaginal laser treatment of genitourinary syndrome of menopause: does the evidence support the FDA safety communication?.
        Menopause. 2020; 27: 1177-1184
        • Mension E.
        • Alonso I.
        • Tortajada M.
        • et al.
        Vaginal laser therapy for genitourinary syndrome of menopause - systematic review.
        Maturitas. 2022; 156: 37-59
        • Juhász M.L.W.
        • Korta D.Z.
        • Mesinkovska N.A.
        Vaginal rejuvenation: a retrospective review of lasers and radiofrequency devices.
        Dermatol Surg. 2021; 47: 489-494
        • Filippini M.
        • Porcari I.
        • Ruffolo A.F.
        • et al.
        CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis.
        J Sex Med. 2022; 19: 452-470
        • Khatri K.A.
        • Ross V.
        • Grevelink J.M.
        • et al.
        Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides.
        Arch Dermatol. 1999; 135: 391-397
        • Lee M.S.
        Treatment of vaginal relaxation syndrome with an Erbium:YAG laser using 90° and 360° scanning scopes: a pilot study & short-term results.
        Laser Ther. 2014; 23: 129-138
        • Elia D.
        • Gambacciani M.
        • Berreni N.
        • et al.
        Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
        Horm Mol Biol Clin Investig. 2019; 41 (Available at:)
        • Vizintin Z.
        • Mario Rivera M.
        • Fistonić I.
        • et al.
        Novel minimally invasive VSP Er:YAG laser treatments in gynecology.
        J LAHA. 2012; (Available at:): 46-58
        • Fistonic I.
        • Findri-Gustek S.
        • Fistonic N.
        Minimally invasive laser procedure for early stages of stress urinary incontinence (SUI).
        J LAHA. 2012; (Available at:): 67-74
        • Gaspar A.
        • Brandi H.
        • Gomez V.
        • et al.
        Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
        Lasers Surg Med. 2017; 49: 160-168
        • Gambacciani M.
        • Levancini M.
        Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
        Menopause. 2017; 24: 316-319
        • Gambacciani M.
        • Levancini M.
        • Russo E.
        • et al.
        Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
        Climacteric. 2018; 21: 148-152
        • Lin K.L.
        • Chou S.H.
        • Loo Z.X.
        • et al.
        The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
        Lasers Med Sci. 2022; 37: 2203-2208
        • Barber M.A.
        • Idoya E.
        Patient satisfaction with vaginal erbium laser treatment of stress urinary incontinence, vaginal relaxation syndrome and genito-urinary syndrome of menopause.
        J LAHA. 2016; No 1 (Available at:): 18-23
        • Dillon B.
        • Dmochowski R.
        Radiofrequency for the treatment of stress urinary incontinence in women.
        Curr Urol Rep. 2009; 10: 369-374
        • Gold M.
        • Andriessen A.
        • Bader A.
        • et al.
        Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation.
        J Cosmet Dermatol. 2018; 17: 289-297
        • Alinsod R.M.
        Transcutaneous temperature controlled radiofrequency for orgasmic dysfunction.
        Lasers Surg Med. 2016; 48: 641-645
        • Leibaschoff G.
        • Izasa P.G.
        • Cardona J.L.
        • et al.
        Transcutaneous temperature controlled radiofrequency (TTCRF) for the treatment of menopausal vaginal/genitourinary symptoms.
        Surg Technol Int. 2016; 29: 149-159
        • Vanaman Wilson M.J.
        • Bolton J.
        • Jones I.T.
        • et al.
        Histologic and clinical changes in vulvovaginal tissue after treatment with a transcutaneous temperature-controlled radiofrequency device.
        Dermatol Surg. 2018; 44: 705-713
        • Millheiser L.S.
        • Pauls R.N.
        • Herbst S.J.
        • et al.
        Radiofrequency treatment of vaginal laxity after vaginal delivery: nonsurgical vaginal tightening.
        J Sex Med. 2010; 7: 3088-3095
        • Sekiguchi Y.
        • Utsugisawa Y.
        • Azekosi Y.
        • et al.
        Laxity of the vaginal introitus after childbirth : nonsurgical outpatient procedure for vaginal tissue restoration and improved sexual satisfaction using low-energy radiofrequency thermal therapy.
        J Womens Health (Larchmt). 2013; 22: 775-781
        • Krychman M.
        • Rowan C.G.
        • Allan B.B.
        • et al.
        Effect of single-treatment, surface-cooled radiofrequency therapy on vaginal laxity and female sexual function: the VIVEVE I randomized controlled trial.
        J Sex Med. 2017; 14: 215-225
        • Vicariotto F.
        • DE Seta F.
        • Faoro V.
        • et al.
        Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
        Minerva Ginecol. 2017; 69: 342-349
        • Clark Z.
        Labial tissue rejuvenation and sexual function improvement using a novel noninvasive focused monopolar radio frequency device.
        J Cosmet Laser Ther. 2018; 20: 66-70
        • Lalji S.
        • Lozanova P.
        Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvo-vaginal laxity and urinary incontinence.
        J Cosmet Dermatol. 2017; 16: 230-234
        • Evans K.L.
        009 Radio frequency volumetric heating for vaginal laxity treatment and effects on sexual satisfaction.
        J Sex Med. 2018; 15: S102
        • Kuzlik R.
        • Kuzlik B.
        Radiofrequency—new solution for treatment of vaginal laxity, urinary incontinence and sexual disorders.
        Gynecol Reprod Health. 2019; 2: 1-4
        • Desai S.A.
        • Vakil Z.
        • Kroumpouzos G.
        Transcutaneous temperature-controlled radiofrequency treatment: improvement in female genital appearance, sexual dysfunction, and stress urinary incontinence.
        Aesthet Surg J. 2021; 41: 1400-1408
        • Pinheiro C.
        • Costa T.
        • Amorim de Jesus R.
        • et al.
        Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
        BMC Womens Health. 2021; 21: 379
        • Pather K.
        • Dilgir S.
        • Rane A.
        The ThermiVa in genital hiatus treatment (TIGHT) study.
        Sex Med. 2021; 9: 100427
        • Wańczyk-Baszak J.
        • Woźniak S.
        • Milejski B.
        • et al.
        Genitourinary syndrome of menopause treatment using lasers and temperature-controlled radiofrequency.
        Prz Menopauzalny. 2018; 17: 180-184
        • Leibaschoff G.
        • De La Torre S.
        Histological outcomes in the treatment of vulvovaginal atrophy using photobiomodulation technology.
        Lasers Surg Med. 2019; 51 (Available at:): 38
        • Alexiades M.
        At-home transvaginal device following fractional carbon dioxide laser treatment for genitourinary syndrome of menopause.
        J Drugs Dermatol. 2020; 19: 1076-1079
        • Frederice C.P.
        • Brito L.G.O.
        • Machado H.C.
        • et al.
        Vaginal stretching therapy and class IIIB vaginal laser treatment for pelvic floor myofascial pain: a randomized clinical trial.
        Lasers Med Sci. 2022; 37: 2421-2430
        • Gaspar A.
        • Addamo G.
        • Brandi H.
        Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation.
        Am J Cosmet Surg. 2011; 28: 156-162
        • Lang P.
        • Dell J.R.
        • Rosen L.
        • et al.
        Fractional CO2 laser of the vagina for genitourinary syndrome of menopause: is the out-of-pocket cost worth the outcome of treatment?.
        Lasers Surg Med. 2017; 49: 882-885